KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Non Operating Income (2017 - 2025)

Twist Bioscience (TWST) has disclosed Non Operating Income for 6 consecutive years, with -$250000.0 as the latest value for Q3 2023.

  • On a quarterly basis, Non Operating Income rose 45.77% to -$250000.0 in Q3 2023 year-over-year; TTM through Sep 2023 was -$671000.0, a 38.27% increase, with the full-year FY2025 number at -$903000.0, up 66.29% from a year prior.
  • Non Operating Income was -$250000.0 for Q3 2023 at Twist Bioscience, down from $41000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $84000.0 in Q1 2021 to a low of -$1.1 million in Q3 2021.
  • A 5-year average of -$187368.4 and a median of -$156000.0 in 2021 define the central range for Non Operating Income.
  • Peak YoY movement for Non Operating Income: tumbled 2750.0% in 2020, then soared 366.67% in 2021.
  • Twist Bioscience's Non Operating Income stood at -$87000.0 in 2019, then rose by 11.49% to -$77000.0 in 2020, then plummeted by 102.6% to -$156000.0 in 2021, then decreased by 0.64% to -$157000.0 in 2022, then crashed by 59.24% to -$250000.0 in 2023.
  • Per Business Quant, the three most recent readings for TWST's Non Operating Income are -$250000.0 (Q3 2023), $41000.0 (Q2 2023), and -$305000.0 (Q1 2023).